Desenvolvimento de um escore de risco poligênico.

Development of a clinical polygenic risk score assay and reporting workflow – Nature Medicine

Comunicado de imprensa: Newly Developed Genetic Risk Scores Could Help Patients, Physicians Make Health Decisions – Brigham and Women’s Hospital

Comentário no Twitter

The first report from the GenoVA Study provides preliminary insights on the development of a polygenic risk score assay in a clinical setting and discusses the challenges of generating, interpreting and reporting results @jasonvassy @MassGenBrigham https://t.co/zNNl35tMSs

— Nature Medicine (@NatureMedicine) April 18, 2022